Research and reports
This report was commissioned by Medicines New Zealand and reviews the public funding of highly innovative modern medicines across eight key therapy areas including cancer, and compares medicine reimbursement within 20 OECD countries between 2011-2017 inclusive.
Overview of the treatment of CLL
Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin.
Clinical features and diagnosis of CLL/small lymphocytic lymphoma
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a mature B cell neoplasm characterized by a progressive accumulation of monoclonal B lymphocytes.
Overview of the complications of CLL
Chronic lymphocytic leukemia (CLL) is characterized by the progressive accumulation of usually monoclonal, functionally incompetent lymphocytes. Patients with CLL commonly develop complications associated with the intrinsic immune dysfunction that results in immunodeficiency and the development of autoimmune disorders.
Staging and prognosis of CLL
Chronic lymphocytic leukemia (CLL) is one of the B cell chronic lymphoproliferative disorders (lymphoid neoplasms). According to the World Health Organization classification, B cell CLL is considered to be identical (ie, one disease with different manifestations) to the mature (peripheral) B cell neoplasm small lymphocytic lymphoma...
Selection of initial therapy for symptomatic or advanced CLL
Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent B lymphocytes, which are usually monoclonal in origin.
Treatment of relapsed or refractory CLL
Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin.